Pfizer Inc on Tuesday said it expected 2021 sales of the COVID-19 vaccine it developed with German partner BioNTech SE to reach $36 billion and forecast another $29 billion from the shot in 2022, topping analyst estimates for both years. Mainstream media is sponsored by Pfizer, but I’m sure there’s no connection to vaccine sales.
Pfizer Pharmaceuticals is having a run the likes of which rarely if ever seen before in modern times, with billions of dollars flowing in every month, due to the mandated use of the COVID-19 vaccine. And to make sure that the money keeps pouring in, Pfizer is sponsoring dozens of news programs on mainstream media, guaranteeing the talking heads will keep enthusiastically recommending that everyone get vaccinated once, twice, three and four times, with booster shots thrown in for good measure. Oh, what the heck, let’s make it a yearly, mandated thing.
“For the love of money is the root of all evil: which while some coveted after, they have erred from the faith, and pierced themselves through with many sorrows. But thou, O man of God, flee these things; and follow after righteousness, godliness, faith, love, patience, meekness.” 1 Timothy 6:10,11 (KJB)
What shows does Pfizer sponsor? Glad you asked, Pfizer sponsors CBS Health Watch, Anderson Cooper 360, ABC News Nightline, Making A Difference, CNN Tonight, Erin Burnett Out Front, ABC’s This Week With George Stephanopoulos, CBS Sports Update, Meet The Press, CBS This Morning, and 60 Minutes, just to name a few. Now you know why the mainstream media relentlessly pushes for all living human beings to receive the government injection. They are ‘sponsored by Pfizer’.
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 billion
FROM REUTERS: The U.S. drugmaker said it is seeking to sign more vaccine deals with countries, which could drive sales even higher next year. It has the capacity to produce 4 billion doses in 2022 and has based its projections on sales of 1.7 billion doses. Still, Chief Executive Albert Bourla said he was concerned that low- and middle-income countries would not place orders for next year’s vaccine doses early enough, and could again end up behind wealthier countries.
“The high-income countries, they have the tendency to be way more proactive, and they are placing their orders,” Bourla said in an interview. “I want to make sure that I go on record publicly… they need to place orders, period.”
Pfizer said it expects to deliver at least one billion doses of its vaccine to low- and middle- income countries next year. The vaccine brought in sales of $13 billion in the third quarter. The company splits gross profit from sales of the shot in most of the world with BioNTech.
Beyond 2022, Pfizer said it expects the market for COVID-19 vaccines to be durable, and continue generating sales for years to come.
Pfizer said it is planning for private markets for the vaccine to emerge sometime in the foreseeable future, particularly in the United States. But Bourla said Pfizer may yet sign another big supply contract with the U.S. government.
“As long as the government thinks they should be going with mass vaccinations that they buy and distribute, we will support them,” he said.
Pfizer shares were up more than 5% at $45.92.
The Pfizer/BioNTech COVID-19 vaccine was the first to receive U.S. authorization last year, and U.S. regulators are likely to give the green light to begin administering it to children ages 5 to 11 as soon as Wednesday. Pfizer’s updated vaccine sales forecast suggests the shot will account for as much as 44% of its total revenue for the year. Wall Street on average expected COVID-19 vaccine sales of $35.44 billion this year and $22.15 billion for 2022, according to Refinitiv data.
Analysts have said that Pfizer and other COVID-19 vaccine makers stand to reap billions of dollars from annual vaccine boosters over the next few years. Pfizer is already planning for a potential clinical study of a fourth dose of the vaccine, which could generate the type of data to support annual vaccination, according to Pfizer Chief Scientific Officer Mikael Dolsten. Pending that data, he said, the company could file for annual COVID-19 vaccinations before next year’s flu season.
U.S. regulators recently authorized a round of booster doses for certain age and risk groups for the Pfizer/BioNTech, Moderna and Johnson & Johnson vaccines in the face of data showing protection can wane over time. Other nations are also administering booster shots. A majority of booster doses are expected to be sold to high-income countries, which pay more for the shots as part of Pfizer’s plan to link the price of its vaccine to a country’s ability to pay.
Sales of the vaccine, called Comirnaty, have vastly outpaced those from rivals Moderna and Johnson & Johnson, who have been unable to keep up with Pfizer’s manufacturing scale-up. The company is on track to deliver 2.3 billion doses of the vaccine, out of the roughly 3 billion it plans to produce this year. Pfizer is also studying an experimental antiviral drug to treat COVID-19. If it receives authorization, they could start supplying doses before the end of the year. READ MORE
The Mainstream Media News Is Sponsored By Pfizer
Now The End Begins is your front line defense against the rising tide of darkness in the last Days before the Rapture of the Church
- HOW TO DONATE: Click here to view our WayGiver Funding page
When you contribute to this fundraising effort, you are helping us to do what the Lord called us to do. The money you send in goes primarily to the overall daily operations of this site. When people ask for Bibles, we send them out at no charge. When people write in and say how much they would like gospel tracts but cannot afford them, we send them a box at no cost to them for either the tracts or the shipping, no matter where they are in the world. Even all the way to South Africa. We even restarted our weekly radio Bible study on Sunday nights again, thanks to your generous donations. All this is possible because YOU pray for us, YOU support us, and YOU give so we can continue growing.
But whatever you do, don’t do nothing. Time is short and we need your help right now. If every one of the 15,860+ people on our daily mailing list gave $4.50, we would reach our goal immediately. If every one of our 150,000+ followers on Facebook gave $1.00 each, we would reach 300% of our goal. The same goes for our 15,900 followers on Twitter. But sadly, many will not give, so we need the ones who can and who will give to be generous. As generous as possible.
“Looking for that blessed hope, and the glorious appearing of the great God and our Saviour Jesus Christ;” Titus 2:13 (KJV)
“Thank you very much!” – Geoffrey, editor-in-chief, NTEB
- HOW TO DONATE: Click here to view our WayGiver Funding page